Edition:
United Kingdom

People: Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ on NASDAQ Stock Exchange Global Select Market

5.07USD
13 Sep 2019
Change (% chg)

$-0.07 (-1.36%)
Prev Close
$5.14
Open
$5.04
Day's High
$5.16
Day's Low
$5.04
Volume
17,090
Avg. Vol
6,730
52-wk High
$7.00
52-wk Low
$4.72

Pavliv, Leo 

Mr. Leo Pavliv, R. Ph., is Senior Vice President - Operations and Chief Development Officer of Cumberland Pharmaceuticals Inc. He is responsible for Cumberland’s overall drug development, including manufacturing and quality operations, and has over 26 years of experience developing pharmaceutical and biological products. From 1997 to 2003, he worked at Cato Research, a contract research organization, most recently as Vice President of Pharmaceutical Development where he oversaw development of a wide variety of products throughout the development cycle. Prior to 1997, he held various scientific and management positions at both large pharmaceutical and smaller biopharmaceutical firms including Parke-Davis from 1984 to 1986, Agouron Pharmaceuticals from 1992 to 1997, ProCyte from 1989 to 1992, and Interferon Sciences from 1986 to 1989. He is a registered pharmacist (R.Ph.) and is regulatory affairs certified. Mr. Pavliv holds a B.S., Pharmacy, and an M.B.A. from Rutgers University.

Basic Compensation

Total Annual Compensation, USD 406,750
Restricted Stock Award, USD 22,900
Long-Term Incentive Plans, USD --
All Other, USD 42,450
Fiscal Year Total, USD 472,100

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

A. Kazimi

995,950

Michael Bonner

--

Martin Cearnal

383,240

Leo Pavliv

472,100

James Herman

299,745

Amy Rock

--
As Of  31 Dec 2014